NCT05922462 Effects of Increased Greek Yogurt Consumption in Youth and Young Adult Athletes
| NCT ID | NCT05922462 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Brock University |
| Condition | Bone Growth Abnormal |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2025-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2023-09-01 with a primary completion date of 2025-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Physical activity and dairy consumption during growth and development are each known to improve peak bone mass in young adults. Peak bone mass, the maximum amount of bone a person will have in their lifetime, is typically reached in the early 20's in females and late 20's in males. However, evidence suggests that young people do not consume enough dairy to maximize their bone mass. The resulting effect in peak bone mass can be troublesome, particularly for athletes, such as volleyball players. This study aims to determine whether increased dairy consumption combined with training can have an additive effect on the physiology of young competitive athletes. Specifically, we will examine whether Greek yogurt consumption will lead to beneficial changes in bone metabolism and inflammation, in adolescent and young adult, male and female athletes, similar to those observed with whey protein supplementation. Many athletes choose exclusively protein supplementation and miss out on other nutrients vital for healthy growth and development. By examining the benefits of Greek yogurt across different athlete age groups and sexes, this work will help reshape the attitudes, beliefs, and behaviours surrounding diet of young athletes.
Eligibility Criteria
Inclusion Criteria: * Competitive youth or varsity athletes Exclusion Criteria: * Presence of injury * Inability to participate in practices * Allergy to dairy foods/dairy protein or * Diagnosis with lactose intolerance
Contact & Investigator
Panagiota Klentrou, PhD
PRINCIPAL INVESTIGATOR
Brock University
Frequently Asked Questions
Who can join the NCT05922462 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 22 Years, studying Bone Growth Abnormal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05922462 currently recruiting?
Yes, NCT05922462 is actively recruiting participants. Contact the research team at nklentrou@brocku.ca for enrollment information.
Where is the NCT05922462 trial being conducted?
This trial is being conducted at St. Catharines, Canada.
Who is sponsoring the NCT05922462 clinical trial?
NCT05922462 is sponsored by Brock University. The principal investigator is Panagiota Klentrou, PhD at Brock University. The trial plans to enroll 40 participants.